EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Terumo's Enterprise Value is $27,281 Mil.
Terumo's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 was $1,064 Mil. Therefore, Terumo's EV-to-EBIT for today is 25.63.
The historical rank and industry rank for Terumo's EV-to-EBIT or its related term are showing as below:
TRUMY'
s EV-to-EBIT Range Over the Past 10 Years
Min: 16.63 Med: 25.12 Max: 35.95
Current: 25.63
During the past 13 years, the highest EV-to-EBIT of Terumo was 35.95. The lowest was 16.63. And the median was 25.12.
TRUMY's EV-to-EBIT is ranked worse than 59.78% of 460
companies
in the Medical Devices & Instruments industry
Industry Median: 19.665
vs TRUMY: 25.63
The historical data trend for Terumo's EV-to-EBIT can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Terumo's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Terumo's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Terumo's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Terumo's EV-to-EBIT falls into.
Terumo's current Enterprise Value is $27,281 Mil.
Terumo's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,064 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terumo (OTCPK:TRUMY) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Terumo's Enterprise Value for the quarter that ended in Mar. 2025 was $27,381 Mil.
Terumo's EBIT for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,064 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Terumo EV-to-EBIT Related Terms
Thank you for viewing the detailed overview of Terumo's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2024, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 36% of Terumo's revenue.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TRUMY has been successfully added to your 